Post Marketing Surveillance Study to Observe Safety and Effectiveness of BOSULIF
Latest Information Update: 29 Jul 2024
At a glance
- Drugs Bosutinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions
- Sponsors Pfizer
Most Recent Events
- 26 Jul 2024 Planned initiation date changed from 1 Mar 2024 to 31 Aug 2024.
- 11 Mar 2024 New trial record